Dovato

GSK’s Dovato Matches Efficacy of Gilead’s Biktarvy in Head-to-Head HIV Trial
BioSpace
Tue, 07/23/24 - 06:29 pm
GSK
Dovato
Gilead Sciences
Biktarvy
clinical trials
HUV
GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen
Fierce Pharma
Mon, 10/5/20 - 11:45 am
GSK
ViiV
Dovato
HIV
ViiV Healthcare gets FDA expanded approval for HIV-1 drug Dovato
Pharmaceutical Business Review
Fri, 08/7/20 - 10:40 am
ViiV Healthcare
FDA
HIV
Dovato
HIV-1
ViiV’s two-drug HIV therapy Dovato gets Japanese approval
Pharmaforum
Thu, 01/16/20 - 11:02 pm
ViiV Healthcare
Dovato
HIV
Japan
GSK's plan to take over the HIV drug market hasn't worked out
BioPharma Dive
Mon, 01/6/20 - 11:47 pm
GSK
FDA
HIV
Dovato
Biktarvy
ViiV Healthcare
Gilead Sciences
Roche's Ocrevus, GSK's Dovato ads top November TV spending charts—behind Humira, of course
Fierce Pharma
Thu, 12/19/19 - 11:06 pm
drug ads
television ads
Roche
Ocrevus
GSK
Dovato
AbbVie
Humira
GSK's ViiV launches first campaign for new HIV med Dovato with real patient ambassadors
Fierce Pharma
Wed, 10/9/19 - 09:49 am
GSK
ViiV Healthcare
Dovato
DTC ads
HIV
ViiV's HIV Drug Hits Endpoints in Late-Stage Comparison Trial
BioSpace
Wed, 07/10/19 - 10:18 am
GSK
ViiV Healthcare
Dovato
HIV
GSK wins U.S. nod for two-drug HIV combination
Yahoo/Reuters
Tue, 04/9/19 - 08:25 am
GSK
FDA
HIV
Dovato